Stabilized CH505 TF chTrimer vaccine

Stabilized CH505 TF HIV envelope trimer · National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Stabilized CH505 TF chTrimer vaccine, covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Evaluating the Safety and Immunogenicity of Stabilized CH505 TF chTrimer in Healthy, HIV-uninfected Adult Participants. [Phase 1]

See pricing